Adverum Biotechnologies
Redwood City, CA
Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
adverum.comCompany Details
Founded
- 2006
Employees
- 155 employees
Raised
- $814,872,576
Headquarters Location
- Redwood City, CA
Public
- Yes
Acquired
- No
CEO
Laurent Fischer
Founders
- Mark Blumenkranz
Company Collections
These are collections Adverum Biotechnologies is a part of. Click on the collection name to view similar companies.
Adverum Biotechnologies' Industries
Adverum Biotechnologies Headquarters Location
Total Amount Raised: $814,872,576
Adverum Biotechnologies Funding Rounds
Post Ipo Equity
$127,500,000
Post Ipo Equity Investors
TCG Crossover ManagementSamsara BioCapitalFrazier Life SciencesLogos CapitalCommodore CapitalVenrock Healthcare Capital PartnersVivo Capital5am VenturesPost Ipo Equity
$217,000,000
Post Ipo Equity
$150,218,750
Post Ipo Equity
$69,000,000
Post Ipo Equity
$50,000,000
Post Ipo Equity
$130,500,000
Post Ipo Equity
$9,999,995
Series B
$55,000,000
Series B Investors
VenrockDeerfield ManagementAdage Capital ManagementRedmile GroupRock Springs CapitalSabby CapitalIPO
Unknown
Series Unknown
$5,653,890
Adverum Biotechnologies Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Adverum Biotechnologies.